Table 2.

Profile of immune cells in CSF of ALS patients and controls.

Immune cells (%)	ALS N = 16 (Mean ± SD)	controls N = 10 (Mean ± SD)	p-value
Lymphocyte	51.59 ± 13.01	39 ± 12.06	0.048*
CD3 + T cells	12.78 ± 17.51	20.74 ± 26.40	0.280
CD4 + T cells	37.89 ± 24.45	41.76 ± 25.77	0.660
CD8 + T cells	16.09 ± 9.39	27.36 ± 19.0	0.140
CD4 + naïve T cells	15.54 ± 7.90	26.08 ± 17.47	0.250
CD4 + memory T cells	20.77 ± 13.85	13.5 ± 8.41	0.130
CD8 + naïve T cells	38.61 ± 20.72	19.52 ± 16.73	0.014*
CD8 + memory T cells	20.84 ± 14.62	21.13 ± 21.12	0.670
B cells	6.93 ± 2.97	11.03 ± 10.28	0.410
Naïve B cells	83.19 ± 11.2	86.34 ± 6.10	0.620
Memory B cells	13.51 ± 5.78	10.44 ± 6.14	0.280
NK cells	9.59 ± 4.77	8.14 ± 3.40	0.410
NK T cells	2.01 ± 1.78	2.14 ± 1.46	0.530
CD4 + NK T cells	25.61 ± 18.81	22.73 ± 25.48	0.340
CD8 + NK T cells	23.41 ± 15.76	37.27 ± 23.79	0.075
Classical Mo	13.28 ± 7.83	15.18 ± 13.06	0.830
Intermediate Mo	8.89 ± 4.27	7.98 ± 5.63	0.670
Nonclassical Mo	7.50 ± 4.52	14.5 ± 13.28	0.220
SlanDCs	4.34 ± 1.98	4.60 ± 2.57	0.920
BDCA1 + DCs	8.69 ± 7.54	6. 9 ± 3.77	0.980